Professor Ken Gall
Implementation of New Materials into Orthopedic Implants
Location: EB1 Room 1011
Friday, December 1st 2017 - 11:00 am
We will discuss the translation of a diverse set of new material technologies into orthopedic implants. In all the applications, the implementation of the new materials was accelerated by basic research leading to a new fundamental understanding of the relationship between processing, structure, and mechanical properties of the constituent materials. The examples span implants and new materials that have been successfully used in nearly ten thousand patients, to materials yet to be cleared in a device by the FDA. The topics to be overviewed include: The development and understanding of deployable shape memory polymers to mitigate damage when reattaching soft tissue to bone. A fundamental breakthrough on the processing and machinability of shape memory alloys to enable a paradigm shift in the success of large bone intramedullary fusion devices. A new approach to the formation of an interconnected surface porosity in a high strength polymer that results in the first ever FDA clearance and clinical success of an all polymer spinal fusion cage with porosity. Finally, a 3D printed, bio-mimetic elastomer is shown to have early promise as a reliable and long-term soft tissue replacement or scaffold.
Professor Gall's technical expertise is in the mechanical properties of materials, and his contributions to the scientific community range from the creation and understanding of multiple new functional biomaterials to the discovery of a new phase transformation in gold nanowires. He has over 200 publications that have been cited over 13,000 times, and his publication H-index is 64. Over the past 20 years he has given over 300 presentations at conferences, companies, and universities. In addition to his research and teaching, he has consulted for various companies, the US Military and the US Intelligence Community. He has also served as an expert witness in multiple patent and product litigations involving materials across several biomedical industries. Finally, he is a passionate entrepreneur who has several dozen patents and has founded two medical device start-up companies, MedShape and Vertera. He works closely with MedShape, Vertera, and other early stage companies to commercialize new technologies in the medical device space.